Last updated on September 2017

An open-label phase IIIb study of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed after standard therapy


Brief description of study

An open-label phase IIIb study of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed after standard therapy

Detailed Study Description

This is a phase III B, prospective, interventional, open-label, single-arm, multicenter study to provide regorafenib to subjects diagnosed with metastatic colorectal cancer who have failed after standard therapy and for whom no therapy alternatives exist, in the time between positive results and approval / availability on the market, and to collect safety data for regorafenib until market access.

Regorafenib is an oral (i.e. taken by mouth) multi-targeted kinase inhibitor. A kinase inhibitor targets certain key proteins that are essential for the survival of the cancer cell. By specifically targeting these proteins, regorafenib may stop cancer growth. The growth of the tumor may be decreased by preventing these specific proteins from functioning.

The primary endpoint of this study will be safety.

For Study Locations, Click Here

Clinical Study Identifier: TX152930

Find a site near you

Start Over

Research Center

Located in: Additional Locations, XX Australia
  Connect »

Research Center

Located in: Additional Locations, XX Austria
  Connect »

Research Center

Located in: Additional Locations, XX Belgium
  Connect »

Research Center

Located in: Additional Locations, XX Canada
  Connect »

Research Center

Located in: Additional Locations, XX France
  Connect »

Research Center

Located in: Additional Locations, XX Germany
  Connect »

Research Center

Located in: Additional Locations, XX Greece
  Connect »

Research Center

Located in: Additional Locations, XX Hungary
  Connect »

Research Center

Located in: Additional Locations, XX Ireland
  Connect »

Research Center

Located in: Additional Locations, XX Israel
  Connect »

Research Center

Located in: Additional Locations, XX Italy
  Connect »

Research Center

Located in: Additional Locations, XX Poland
  Connect »

Research Center

Located in: Additional Locations, XX Russian Federation
  Connect »

Research Center

Located in: Additional Locations, XX Spain
  Connect »

Research Center

Located in: Additional Locations, XX Sweden
  Connect »

Research Center

Located in: Additional Locations, XX United Kingdom
  Connect »

Research Center

Located in: Additional Locations, CA USA
  Connect »

Research Center

Located in: Additional Locations, FL USA
  Connect »

Research Center

Located in: Additional Locations, GA USA
  Connect »

Research Center

Located in: Additional Locations, IL USA
  Connect »

Research Center

Located in: Additional Locations, KY USA
  Connect »

Research Center

Located in: Additional Locations, LA USA
  Connect »

Research Center

Located in: Additional Locations, MA USA
  Connect »

Research Center

Located in: Additional Locations, MS USA
  Connect »

Research Center

Located in: Additional Locations, NY USA
  Connect »

Research Center

Located in: Additional Locations, NC USA
  Connect »

Research Center

Located in: Additional Locations, PA USA
  Connect »

Research Center

Located in: Additional Locations, TN USA
  Connect »

Research Center

Located in: Additional Locations, TX USA
  Connect »

Research Center

Located in: Additional Locations, VA USA
  Connect »

Research Center

Located in: Additional Locations, WA USA
  Connect »

Research Center

Located In: Additional Locations, DC USA
  Connect »

Research Center

Located In: Additional Locations, MI USA
  Connect »

Research Center

Located In: Additional Locations, MN USA
  Connect »

Research Center

Located In: Additional Locations, OH USA
  Connect »

Research Center

Located in: Additional Locations, XX Denmark
  Connect »

Research Center

Located in: Additional Locations, XX Netherlands
  Connect »

Research Center

Located in: Additional Locations, CT USA
  Connect »

Research Center

Located in: Additional Locations, OR USA
  Connect »

Research Center

Located in: Additional Locations, SC USA
  Connect »

Research Center

Located In: Additional Locations, CO USA
  Connect »

Research Center

Located In: Additional Locations, ME USA
  Connect »

Research Center

Located In: Additional Locations, NE USA
  Connect »

Research Center

Located In: Additional Locations, NV USA
  Connect »

Research Center

Located In: Additional Locations, ND USA
  Connect »

Research Center

Located In: Additional Locations, RI USA
  Connect »

Research Center

Located in: Additional Locations, IO USA
  Connect »

Research Center

Located in: Additional Locations, NH USA
  Connect »

Research Center

Located In: Additional Locations, XX Finland
  Connect »

Research Center

Located In: Additional Locations, XX Mexico
  Connect »

Research Center

Located In: Additional Locations, XX Norway
  Connect »

Research Center

Located In: Additional Locations, XX Portugal
  Connect »

Research Center

Located In: Additional Locations, XX Switzerland
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.